Company news

OraSure Technologies, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

August 2, 2023

OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd

July 19, 2023

OraSure Technologies Elects Robert McMahon to the Board of Directors

July 19, 2023

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

June 12, 2023

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

May 9, 2023

2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5: 00 p.m. ET

May 2, 2023

OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability

February 13, 2023

2022 Fourth Quarter Earnings Conference Call Tuesday, February 14, 2023, 5: 00 p.m. ET

February 6, 2023

OraSure Technologies Continues its Dedication to Ending the HIV Epidemic

November 30, 2022

OraSure Technologies to Present at Stephens Annual Investment Conference

November 13, 2022

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

November 7, 2022

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

November 2, 2022

InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store

November 1, 2022

2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5: 00 p.m. ET

October 31, 2022

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

September 27, 2022

OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention

September 19, 2022

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health

September 13, 2022

OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

August 8, 2022

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5: 00 p.m. ET

August 1, 2022

OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

July 27, 2022

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

July 13, 2022

OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

June 7, 2022

InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing

May 24, 2022

Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure

May 22, 2022

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

May 16, 2022

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

May 9, 2022

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5: 00 p.m. ET

May 2, 2022

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

April 6, 2022

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

March 30, 2022

OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role

March 21, 2022

OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up

February 22, 2022

OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5: 00 p.m. ET

February 15, 2022

InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App

January 30, 2022

OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe

January 24, 2022

InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants

January 12, 2022

OraSure Technologies Announces Actions to Enhance Stockholder Value

January 4, 2022

OraSure Technologies Announces 2022 Annual Meeting Date

December 13, 2021

OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus

November 29, 2021

OraSure Technologies to Present at Upcoming Investor Conferences

November 18, 2021

OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary

November 8, 2021

OraSure Technologies Appoints Two New Members to the Board of Directors

November 7, 2021

OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22

November 2, 2021

U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

November 1, 2021

OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5: 00 p.m. ET

October 26, 2021

OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test

October 3, 2021

OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver

September 22, 2021

OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response

September 19, 2021

OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan

September 1, 2021

OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

August 2, 2021

OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5: 00 p.m. ET

July 26, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 16 calls. Every call is listed under its year.

Decks

The 5 newest of 24 decks. Every deck is listed under its year.